Daliresp
$ 68,00 – $ 220,00Price range: $ 68,00 through $ 220,00
Dapasmart
$ 67,00 – $ 575,00Price range: $ 67,00 through $ 575,00
Danazol
$ 62,00 – $ 480,00Price range: $ 62,00 through $ 480,00
Danazol is a synthetic androgen used to effectively manage symptoms associated with endometriosis and other hormone-related conditions. It works by suppressing the production of certain hormones, which helps reduce pelvic pain and the growth of abnormal tissue. This medication is also indicated for the treatment of severe fibrocystic breast disease to alleviate persistent pain and tenderness. Furthermore, Danazol is used to prevent swelling episodes in patients diagnosed with hereditary angioedema. Its specialized formula provides a reliable therapeutic option for improving the quality of life for those managing these specific health challenges.
Active substance: Danazol
SKU:
Danazol
Category: Woman's Health
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Danazol belongs to a class of medications known as synthetic androgen derivatives that act as pituitary gonadotropin inhibitors. In the United States, Danazol is a prescription-only medication regulated under federal law as a Schedule III controlled substance due to its structural relation to testosterone. It exerts its primary pharmacological effect by altering the feedback mechanism of the hypothalamic-pituitary-ovarian axis and suppressing pituitary gonadotropin output.
This medication is approved by the U.S. Food and Drug Administration (FDA) for the clinical management of endometriosis, prevention of hereditary angioedema (HAE) attacks, and treatment of severe fibrocystic breast disease. Because Danazol presents significant systemic hormonal activity and specific cardiovascular, hepatic, and teratogenic warnings, therapy must be initiated and managed under the strict supervision of a licensed healthcare provider.
| Parameter | Specification |
|---|---|
| Active ingredient | Danazol |
| Therapeutic class | Pituitary Gonadotropin Inhibitor / Synthetic Androgen |
| Dosage form | Oral capsule |
| Route of administration | Oral |
| Prescription status | Prescription (Rx only, Schedule III Controlled Substance) |
| Primary purpose | Management of endometriosis, hereditary angioedema, and fibrocystic breast disease |
Drug Overview and Clinical Profile
Mechanism of action
The therapeutic effect of Danazol stems from its capacity to suppress the pituitary-ovarian axis. The drug inhibits the pre-ovulatory surge of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland. Beyond gonadotropin suppression, Danazol directly binds to androgen, progesterone, and glucocorticoid receptors, while lacking intrinsic estrogenic or progestational activity. By creating a high-androgen, low-estrogen hormonal environment, Danazol leads to anovulation and induces regression and atrophy of ectopic and normal endometrial tissue. In hereditary angioedema, Danazol works through a distinct pathway: it increases total serum levels of the C1 esterase inhibitor, thereby raising levels of the C4 component of the complement system to prevent acute swelling attacks.
Main uses
Danazol is FDA-approved for three primary indications. First, it is indicated for the treatment of endometriosis amenable to hormonal management in patients where alternative therapies are contraindicated or ineffective. Second, it is indicated for the prevention of cutaneous, abdominal, or laryngeal attacks of hereditary angioedema in male and female patients. Third, Danazol is indicated for the symptomatic relief of severe fibrocystic breast disease that has failed to respond to conservative measures such as analgesics and supportive garments. Additionally, clinicians may utilize Danazol in off-label indications–such as refractory immune thrombocytopenic purpura (ITP) or autoimmune hemolytic anemia–when standard immunosuppressive regimens provide inadequate response. Off-label applications require individual evaluation by the prescribing practitioner.
Dosing schedule
The dosing schedule for Danazol depends entirely upon the medical indication, disease severity, and individual patient response. For endometriosis, the typical starting dose ranges from 200 mg to 800 mg daily given in two divided doses, usually initiated during menstruation to rule out pregnancy. Therapy for endometriosis generally continues uninterrupted for 3 to 6 months, though treatment may extend to 8 months if necessary. For hereditary angioedema, initial dosing typically starts at 200 mg two to three times daily, after which the dosage is gradually titrated down to the lowest effective maintenance dose required to prevent attacks. For fibrocystic breast disease, doses range between 100 mg and 400 mg daily divided into two doses. Dosing must always be strictly tailored by the attending physician.
How it’s absorbed and eliminated
Following oral administration, Danazol is absorbed from the gastrointestinal tract, reaching peak plasma concentration within approximately 2 to 4 hours. Administration alongside food enhances peak bioavailability. Danazol undergoes extensive hepatic metabolism, transforming into primary active metabolites including 2-hydroxymethyldanazol and ethisterone. The elimination half-life displays considerable inter-individual variation, ranging from 4.5 hours up to 24 hours depending on chronic dosing parameters. The systemic elimination of Danazol and its metabolites occurs primarily through renal excretion in urine and fecal elimination.
Food and alcohol interactions
Consuming high-fat meals significantly increases the maximum serum concentration (Cmax) and total area under the curve (AUC) of Danazol. Patients should maintain a consistent relationship between drug administration and meal timing to prevent fluctuating blood levels. Alcohol consumption should be avoided or severely restricted during Danazol therapy. Because both alcohol and Danazol undergo primary metabolic processing in the liver, concurrent use increases the metabolic workload on hepatic tissue and elevates the potential risk of liver enzymes elevation or gastrointestinal distress.
Safety, Interactions, and FAQ
Important precautions
Danazol carries critical boxed warnings and safety precautions established in its official FDA prescribing labeling. The drug is strictly contraindicated during pregnancy due to the severe risk of virilization in a female fetus; effective non-hormonal contraception must be confirmed prior to treatment. Danazol is contraindicated in patients with marked hepatic, renal, or cardiac dysfunction, as well as those with undiagnosed abnormal genital bleeding or active thromboembolic disease. FDA warnings highlight risks of peliosis hepatis, benign hepatic adenomas, benign intracranial hypertension (pseudotumor cerebri), and thromboembolic events such as deep vein thrombosis and stroke. Patients presenting with persistent headaches, visual disturbances, or severe abdominal pain require immediate evaluation. Hepatic function parameters and serum lipid profiles (due to potential reductions in HDL cholesterol) must be evaluated periodically during prolonged therapy.
Adverse reactions
Side effects associated with Danazol stem from its androgenic and hypoestrogenic properties. Androgenic side effects include weight gain, acne, oily skin, hirsutism, fluid retention, voice deepening or hoarseness, and clitoral hypertrophy. Hypoestrogenic side effects frequently include hot flashes, vaginal dryness, emotional lability, nervous system instability, and alterations in menstrual bleeding patterns (ranging from spotting to complete amenorrhea). Less frequent but serious adverse reactions involve hepatic enzyme elevations, cholestatic jaundice, decreases in high-density lipoproteins (HDL), increases in low-density lipoproteins (LDL), and thromboembolic events. Voice changes may become irreversible in some individuals if therapy is continued after onset.
Compatibility with other medicines
Danazol exhibits significant pharmacokinetic interactions with several therapeutic drug classes:
- Warfarin and oral anticoagulants: Danazol prolongs prothrombin time and significantly enhances the anticoagulant activity of warfarin, raising the risk of severe bleeding. Frequent INR monitoring is required.
- Statins (HMG-CoA reductase inhibitors): Co-administration with agents such as simvastatin or atorvastatin increases the risk of myopathy and rhabdomyolysis due to inhibited statin clearance.
- Anticonvulsants: Danazol can elevate serum levels of carbamazepine, increasing the likelihood of carbamazepine toxicity.
- Immunosuppressants: Danazol inhibits the metabolism of cyclosporine and tacrolimus, raising blood concentrations of these agents and increasing nephrotoxicity risks.
- Antidiabetic agents: Danazol can alter insulin sensitivity and glucose tolerance, necessitating adjustment of insulin or oral hypoglycemic dosages.
If you skip a dose
If a dose of Danazol is missed, it should be taken as soon as remembered on the same day. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped entirely, and the standard dosing schedule resumed. Patients must never double the dose or take extra capsules to compensate for a missed dose.
Storage and expiration
Danazol capsules should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F) in accordance with USP regulations. Store the medication in its original light-resistant, tightly closed container away from excessive moisture, heat, and direct sunlight. Keep out of reach of children and pets. Expired medications should be disposed of properly through pharmacy take-back programs or local waste disposal guidance.
Pregnancy, breastfeeding, and other groups
Danazol is contraindicated during pregnancy (FDA Pregnancy Category X equivalent). Exposure during gestation can cause virilization of the female fetus, resulting in anatomical alterations such as clitoromegaly and labial fusion. Female patients of childbearing potential must undergo pregnancy testing immediately prior to starting therapy and use effective non-hormonal contraception throughout treatment. Breastfeeding is contraindicated because Danazol is excreted into human milk and carries potential androgenic risks to the nursing infant. Elderly patients should be evaluated carefully, as age-related decreases in hepatic or renal clearance increase susceptibility to adverse effects.
Frequently asked questions
Can Danazol cause permanent voice changes?
Yes, voice deepening or persistent hoarseness can occur as an androgenic side effect of Danazol. If voice changes develop, healthcare providers typically recommend discontinuing the medication, as these alterations may be irreversible even after stopping therapy.
Why is routine lipid testing required during treatment with Danazol?
Danazol significantly alters lipid metabolism, frequently causing marked reductions in high-density lipoprotein (HDL) cholesterol and elevations in low-density lipoprotein (LDL) cholesterol. Laboratory monitoring allows clinicians to evaluate cardiovascular risk factors during extended courses of treatment.
Does Danazol completely stop menstrual periods?
Amenorrhea (absence of menstrual periods) is a common hypoestrogenic effect during Danazol therapy, particularly at higher doses used for endometriosis. Normal menstrual cycles generally resume within 1 to 3 months after discontinuing the medication.
How does Danazol interact with blood thinners?
Danazol potentiates the therapeutic and toxic effects of coumarin anticoagulants like warfarin by interfering with hepatic clearance and clotting factor synthesis. Patients receiving both drugs require close monitoring of prothrombin time and INR to prevent severe bleeding complications.
In accordance with FDA requirements.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
50mg ,100mg ,200mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills |
| Ενεργός Ουσία |
Related products
Altraz
$ 194,00 – $ 441,00Price range: $ 194,00 through $ 441,00
Active substance: Anastrozole
More Details
This product has multiple variants. The options may be chosen on the product page
Aygestin
$ 58,00 – $ 290,00Price range: $ 58,00 through $ 290,00
Active substance: Norethindrone
More Details
This product has multiple variants. The options may be chosen on the product page
Betahistine
$ 41,00 – $ 311,00Price range: $ 41,00 through $ 311,00
Active substance: Betahistine
More Details
This product has multiple variants. The options may be chosen on the product page
Cabgolin
$ 134,00 – $ 356,00Price range: $ 134,00 through $ 356,00
Active substance: Cabergoline
More Details
This product has multiple variants. The options may be chosen on the product page
Cycrin
$ 52,00 – $ 347,00Price range: $ 52,00 through $ 347,00
Active substance: Medroxyprogesterone
More Details
This product has multiple variants. The options may be chosen on the product page
Enclomisign
$ 85,00 – $ 189,00Price range: $ 85,00 through $ 189,00
Active substance: Enclomiphene
More Details
This product has multiple variants. The options may be chosen on the product page
Estriol Cream
$ 13,00 – $ 93,00Price range: $ 13,00 through $ 93,00
Active substance: Estriol
More Details
This product has multiple variants. The options may be chosen on the product page
Female Cialis Soft
$ 40,00 – $ 288,00Price range: $ 40,00 through $ 288,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
